Video

Dr. Casey Seideman on underrepresentation of women in AUA prestigious recognition awards

Author(s):

Urology Times staff

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Casey Seideman, MD, discusses her research study published in the Journal of Urology, which showed that although women represent an increasing percentage of the urology workforce, they continue to be underrepresented in receiving recognition awards from the American Urological Association. Seideman is assistant professor of Urology, School of Medicine, Oregon Health & Science University.

      Related Videos
      Anna Myers, CNP, answers a question during a Zoom video interview
      Urology CNP discusses sensitivity in communication, physical exam
      Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
      Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
      Drug costs | Image Credit: © pixelrobot - stock.adobe.com
      Urologist discusses drug cost savings, price transparency
      Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
      Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
      Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
      Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
      Raymond Xu, MD, answers a question during a Zoom video interview
      Raymond Xu, MD, discusses Cost Plus Drugs and urogynecologic medications
      Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause
      Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause
      Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
      Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
      Jason Hafron, MD, considers the future for AI in urology
      Jason Hafron, MD, considers the future for AI in urology
      Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
      Why a personalized approach is key to prolapse and OAB management
      Related Content
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      April 14th 2025

      Coding Q&A: How to bill for second-generation stone device

      Jonathan Rubenstein, MD Mark Painter
      Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.
      Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
      April 29th 2025

      Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025

      Amy M. Pearlman, MD Rachel Rubin, MD
      Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.
      Drug Costs | Image Credit: © pixelrobot - stock.adobe.com
      April 4th 2025

      Cutting drug costs for patients: key takeaways for urologists

      Benjamin Pockros, MD, MBA
      "The Inflation Reduction Act was a major step in the right direction. The question now is going to be, are commercial insurers going to follow Medicare and enact the same cap that they have as well," says Benjamin Pockros, MD, MBA.
      Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
      April 28th 2025

      Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause

      Melissa Kaufman, MD, PhD, FACS
      In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
      FDA grants marketing authorization to at-home diagnostic test for STIs
      March 28th 2025

      FDA grants marketing authorization to at-home diagnostic test for STIs

      Hannah Clarke
      The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.
      Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
      March 25th 2025

      Expert discusses unique mechanism of action of UTI treatment gepotidacin

      Ryan Haumschild, PharmD, MS, MBA, CPEL
      "I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.
      © 2025 MJH Life Sciences

      All rights reserved.